Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 10/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.36 |
| ▸ | IDO1 | P14902 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13854404 | 0.83 | ACHE (0.62) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| SCHEMBL4611923 | 0.77 | ACHE (0.71) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| SCHEMBL4612908 | 0.77 | ACHE (0.41) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| SCHEMBL12020272 | 0.77 | ACHE (0.56) | ACHETSHRALDH1A1MAPK1TDP1 | |
| SCHEMBL9013920 | 0.77 | ACHE (0.56) | ACHETSHRALDH1A1MAPK1TDP1 | |
| Iodide SCHEMBL9985272 | 0.75 | ACHE (0.54) | ACHETSHRALDH1A1MAPK1TDP1 | |
| SCHEMBL5436496 | 0.74 | APOBEC3A (0.50) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| SCHEMBL10053238 | 0.74 | ACHE (0.39) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| SCHEMBL18644115 | 0.74 | ACHE (0.45) | ACHEALDH1A1CYP3A4TAAR1IDO1 | |
| SCHEMBL12339274 | 0.72 | ACHE (0.44) | ACHETSHROPRM1BLMSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9601696-B2 | Electroluminescent composition and electric device with high brightness | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-03-21 | — | — | US | disclosed |
| US-8741264-B2 | Self-sterilizing products | MOLTENI THERAPEUTICS S.R.L. (IT) | 2014-06-03 | — | — | US | disclosed |
| US-8664382-B2 | Antibacterial compositions comprising metal phthalocyanine analogues | MOLTENI THERAPEUTICS S.R.L. (IT) | 2014-03-04 | — | — | US | disclosed |
| US-8288528-B2 | Meso-substituted porphyrins | L. Molteni & C. Dei Fratelli Alitti—Società di Esercizio S.p.A. (IT) | 2012-10-16 | — | — | US | disclosed |
| US-8242262-B2 | Process for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA'DI ESERCIZIO S.P.A. (IT) | 2012-08-14 | — | — | US | disclosed |
| US-8106031-B2 | Hydrolytically-resistant boron-containing therapeutics and methods of use | ANACOR PHARMACEUTICALS, INC. (US) | 2012-01-31 | — | — | US | disclosed |
| US-7947674-B2 | Meso-substituted porphyrins | L. Molteni & C. Dei Fratelli Alitti (IT) | 2011-05-24 | — | — | US | disclosed |
| US-20110112464-A1 | MESO-SUBSTITUTED PORPHYRINS | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA DI ESERCIZIO S.P.A. (IT) | 2011-05-12 | — | — | US | disclosed |
| US-7749991-B2 | Substituted metal-phthalocyanines, their preparation and the use thereof | L. MOLTENI & C. DEI FRATELLI ALITTI-SOCIETA DI ESERCIZIO S.P.A. (IT) | 2010-07-06 | — | — | US | disclosed |
| US-20090131393-A1 | Process for Preparing Chlorides of Phthalocyanine Derivatives Comprising at Least a Quaternary Ammonium Group | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.P.A. (IT) | 2009-05-21 | — | — | US | disclosed |
| US-20090130049-A1 | Self-Sterilizing Products | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.P.A. (IT) | 2009-05-21 | — | — | US | disclosed |
| US-20070066513-A1 | Substituted metal-phthalocyanines, their preparation and the use thereof | MOLTENI THERAPEUTICS S.R.L. (IT) | 2007-03-22 | — | — | US | disclosed |
| WO-2007000473-A1 | USE OF PHTHALOCYANINE DERIVATES FOR THE NON-PHOTODYNAMIC TREATMENT OF DISEASES | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.P.A. (IT) | 2007-01-04 | — | — | WO | disclosed |
| US-4036824-A | Disazo dyestuffs containing A-O-alkylene-O-SO3 H group | BAYER AKTIENGESELLSCHAFT (DT) | 1977-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066513-A1 | Substituted metal-phthalocyanines, their preparation and the use thereof | CD47, CD99, MEN1 | ACHE 4793/4885TSHR 4409/4885OPRM1 4197/4885 |
| US-20090131393-A1 | Process for Preparing Chlorides of Phthalocyanine Derivatives Comprising at Least a Quaternary Ammonium Group | PHLPP1, PHPT1, PHLPP2 | ACHE 4182/4885TSHR 4476/4885OPRM1 4825/4885 |
| US-20090130049-A1 | Self-Sterilizing Products | NASP, ZP1, SPAG5 | ACHE 4720/4885TSHR 4384/4885OPRM1 4872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.